HOME › DRUGS › EPINEPHRINE
ACTIVE SUBSTANCE / INN

EPINEPHRINE

Brand name(s): Neffy, LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE, PROCAINE HYDROCHLORIDE W/ EPINEPHRINE, Eurneffy, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, SYMJEPI, EPINEPHRINE, ADRENALIN, BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE, IONTOCAINE
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
DISCONTINUED
NDA204200
NDA207534
ACTIVE SUBSTANCE
Epinephrine
REGULATORS
FDA · EMA
SPONSORS / MAH
HOSPIRA, ADAMIS PHARMS CORP, WEST-WARD PHARMS INT
TOTAL APPLICATIONS
12
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINEANDA083389DELL LABSDiscontinued
EPINEPHRINENDA209359HOSPIRAPrescription
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINEANDA071168HOSPIRAPrescription
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEANDA080406WEST-WARD PHARMS INTDiscontinued
PROCAINE HYDROCHLORIDE W/ EPINEPHRINEANDA080758BEL MARDiscontinued
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEANDA089635HOSPIRAPrescription
ADRENALINNDA204200PH HEALTHPrescription
SYMJEPINDA207534ADAMIS PHARMS CORPPrescription
SYMJEPINDA207534ADAMIS PHARMS CORPDiscontinued
IONTOCAINENDA020530IOMEDDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EurneffyALK-Abelló A/SAuthorised22/08/2024Anaphylaxis
NeffyArs Pharmaceuticals Irl LimitedApplication withdrawnHypersensitivity;Anaphylaxis

FULL INTELLIGENCE ON EPINEPHRINE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →